Physician profile
William H Hall
NPI 1790768513
$388.76
in general payments reported to CMS, 2019-2025
10 companies · $64.98 in 2025
The $64.98 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $88.99 · 2023: $135 · 2024: $99.55 · 2025: $64.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $116.32 | 2021-2023 | Halcyon |
| Abbvie INC. | $47.14 | 2023-2024 | |
| Boston Scientific Corporation | $46.50 | 2025 | Spaceoar Vue System - 10ml |
| Accuray Incorporated | $37.39 | 2024 | |
| Janssen Biotech, INC. | $34.67 | 2023 | Erleada |
| Dendreon Pharmaceuticals LLC | $28.76 | 2023 | Provenge |
| Astrazeneca Pharmaceuticals LP | $23.99 | 2024 | Calquence |
| E.R. Squibb & Sons, L.L.C. | $20.75 | 2023 | Opdivo |
| Novartis Pharmaceuticals Corporation | $18.48 | 2025 | |
| Blueprint Medicines Corporation | $14.76 | 2024 | Ayvakit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.